Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2023-A01109-36 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Night shift work is well known to cause health disruption in short and long term. It has been reported that among healthcare workers, nurses slept less than 6 h/24h. Consequences of such short sleep duration has been associated to long term issues such as endothelial dysfunction associated with cardiovascular diseases, arterial hypertension and type 2 diabetes. Countermeasures such as nap at work has potential effects on reducing the prevalence of cardiovascular diseases. However, to our knowledge, no studies have objectively investigated the effects of napping on endothelial function in a longitudinal design. Therefore, this study aims to investigate the effect of a 30 minutes on-duty nap during night work for 12 weeks on caregivers endothelial dysfunction.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Nap group | Experimental | The experimental group will be allocated to do a 30-min on-duty nap during night work, in a dedicated room between 1 am and 4 am. |
|
| Control group | Active Comparator | The control group will be allocated to rest in a dedicated room without napping between 1 am and 4 am. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| On-duty Nap | Behavioral | For 12 weeks, an opportunity for a 30-minute nap during the night shift, between 1 a.m. and 4 a.m., in a quiet room with facilities for lying down. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Evolution of reactive hyperemia index (RHI) | RHI is measured through the EndoPAT device® initially and at 12 weeks, and corresponds to the vascular reactivity following a 5-min occlusion on an arm | Change between week 1 and 12 |
| Measure | Description | Time Frame |
|---|---|---|
| Evolution of pulse wave velocity (PWV) | PWV is measured through the Popmeter® initially and at 12 weeks, and corresponds to the finger-o-foot pulse wave velocity(m/s) | Change between week 1 and 12 |
| Evolution of blood pressure |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Frédéric ROCHE, MD PhD | Centre Hospitalier Universitaire de Saint Etienne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chu de Saint-Etienne | Saint-Etienne | 42055 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41571410 | Derived | Bouchou Y, Monnier M, Roche F, Pelissier C, Berger M. Effect of 12 weeks with a 30-min nap opportunity during the night shift of healthcare workers on early cardiovascular risk biomarkers: the NAPWORK study protocol of a randomised controlled trial. BMJ Open. 2026 Jan 22;16(1):e110108. doi: 10.1136/bmjopen-2025-110108. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Control condition (30-min rest) | Behavioral | For 12 weeks, an opportunity for a 30-minute rest during the night shift, between 1 a.m. and 4 a.m., in a quiet room without facilities for lying down or napping. |
|
| EndoPAT | Device | The EndoPAT device® measures vascular reactivity after a 5-minute occlusion on one arm. This device measures changes in vascular tone induced by the endothelium at fingertip level using a pair of plethysmographic sensors. The measurement consists of performing a reference recording for 5 minutes on the 2 arms, then a test arm is chosen to perform an occlusion for 5 minutes while continuing the recording. |
|
| Popmeter® | Device | The tool is connected to the caregiver's finger and toe via photodiode sensors. Its simple operation enables reproducible measurement of the propagation speed of the pulse wave in 14 seconds. |
|
| Panasonic EW3109 | Device | Diastolic and systolic blood pressure measured 3 times in succession using an automatic blood pressure monitor (Panasonic EW3109) in the sitting position on the left arm. |
|
|
| ECG Holter | Device | The Holter takes an ECG during the subject's daily activities at home. |
|
|
| Fasting blood sample | Biological | 15 ml blood sample (venous sampling) will be taken to measure inflammatory biomarkers (hsCRP, IL-6 TNF-α, IL-1β) and blood markers of endothelial function (NO, CRP, SOD, IL-18). |
|
| Pichot fatigue scale | Other | The Pichot fatigue scale is an 8-item questionnaire, with a score above 22 indicating excessive fatigue. |
|
| French version of the Recovery Needs Scale (BRD) | Other | BRD questionnaire consists of 11 items coded 0 or 1. A score is calculated for each participant, multiplied by 10 to give a score ranging from 0 to 100. The greater the need for recovery, the higher the score. |
|
| The Short-Form 36 (SF-36) | Other | The SF-36 questionnaire is used to assess quality of life. It comprises 8 sub-scores ranging from 0 (minimum quality of life) to 100 (maximum well-being). |
|
| Pittsburgh Sleep Quality Index (PSQI) | Other | 24-question sleep quality assessment scale, a score > 5 indicates poor sleep quality |
|
| Epworth questionnaire | Other | 8-question sleepiness assessment scale, a score above 10 indicates excessive sleepiness |
|
| The Karolinska Sleepiness Scale | Other | The Karolinska Sleepiness Scale measures daytime sleepiness on a 9-point scale, based on 5 states and 4 intermediate states that are not verbally indicated. |
|
| Actimeter | Device | An actimeter will be worn on the non-dominant wrist, uninterrupted day and night, for 7 consecutive days. |
|
Systolic and diastolic blood pressure (mm Hg) measured in the sitting position in triplicate with an automatic blood pressure device (Panasonic EW3109) on the left arm, initially and at 12 weeks.
| Change between week 1 and 12 |
| Evolution of heart rate variability (HRV) | 24-h Holter-Electrocardiogram to derive temporal (SDNN, rMSSD, pNN50) and frequency (LF, HF, LF/HF) HRV indices initially and at 12 weeks. | Change between week 1 and 12 |
| Evolution of pro-inflammatory biomarkers | Fasting blood sample to measure hsCRP, IL-6 TNF-α, IL-1β initially and at 12 weeks. | Change between week 1 and 12 |
| Evolution of blood markers of endothelial function | Fasting blood sample to measure NO, SOD, IL-18 initially and at 12 weeks. | Change between week 1 and 12 |
| Evolution of subjective Fatigue | The Pichot fatigue scale (composed of 8 items, a score above 22 indicates excessive fatigue), initially and at 12 weeks. | Change between week 1 and 12 |
| Evolution of recovery Needs | French version of the Recovery Needs Scale (BRD), initially and at 12 weeks, wich consists of 11 items coded 0 or 1. A score is calculated for each participant, multiplied by 10 to give a score ranging from 0 to 100. The greater the need for recovery, the higher the score. | Change between week 1 and 12 |
| Evolution of state of health | The SF-36 questionnaire is used to assess quality of life, initially and at 12 weeks. It comprises 8 sub-scores ranging from 0 (minimum quality of life) to 100 (maximum well-being). | Change between week 1 and 12 |
| Evolution of sleep quality | Pittsburgh Sleep Quality Index (PSQI), initially and at 12 weeks : 24-question sleep quality assessment scale, a score > 5 indicates poor sleep quality. | Change between week 1 and 12 |
| Evolution of subjective sleepiness | Epworth questionnaire, initially and at 12 weeks : 8-question sleepiness assessment scale, a score above 10 indicates excessive sleepiness | Change between week 1 and 12 |
| Evolution of alertness at work assessed | The Karolinska Sleepiness Scale measures daytime sleepiness on a 9-point scale, based on 5 states and 4 intermediate states that are not verbally indicated, initially and at 12 weeks. | Change between week 1 and 12 |
| Evolution of sleep time | Actimeter measuring variations in wake-up and bedtimes, sleep duration, energy expenditure and time spent at different levels of physical activity intensity (sedentary, light intensity, moderate to intense intensity), initially and at 12 weeks. | Change between week 1 and 12 |
| Evolution of sleep duration | Actimeter measuring variations in wake-up and bedtimes, sleep duration, energy expenditure and time spent at different levels of physical activity intensity (sedentary, light intensity, moderate to intense intensity), initially and at 12 weeks. | Change between week 1 and 12 |
| ID | Term |
|---|---|
| C092779 | RE1-silencing transcription factor |
| D015716 | Electrocardiography, Ambulatory |
| ID | Term |
|---|---|
| D004562 | Electrocardiography |
| D006334 | Heart Function Tests |
| D003935 | Diagnostic Techniques, Cardiovascular |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D004568 | Electrodiagnosis |
| D018670 | Monitoring, Ambulatory |
| D008991 | Monitoring, Physiologic |
Not provided
Not provided